ATE117997T1 - 4-(hetero)arylmethyloxy-phenyl-diazolderivate, verfahren zu deren herstellung und ihre therapeutische verwendung. - Google Patents

4-(hetero)arylmethyloxy-phenyl-diazolderivate, verfahren zu deren herstellung und ihre therapeutische verwendung.

Info

Publication number
ATE117997T1
ATE117997T1 AT91900836T AT91900836T ATE117997T1 AT E117997 T1 ATE117997 T1 AT E117997T1 AT 91900836 T AT91900836 T AT 91900836T AT 91900836 T AT91900836 T AT 91900836T AT E117997 T1 ATE117997 T1 AT E117997T1
Authority
AT
Austria
Prior art keywords
derivatives
arylmethyloxy
hetero
phenyl
alkyl
Prior art date
Application number
AT91900836T
Other languages
English (en)
Inventor
Jean-Jacques Koenig
Luc Lebreton
Maryse Masson
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Application granted granted Critical
Publication of ATE117997T1 publication Critical patent/ATE117997T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C243/24Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
    • C07C243/38Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/101,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C07D271/1131,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT91900836T 1989-11-24 1990-11-23 4-(hetero)arylmethyloxy-phenyl-diazolderivate, verfahren zu deren herstellung und ihre therapeutische verwendung. ATE117997T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8915499A FR2655044B1 (fr) 1989-11-24 1989-11-24 Derives d'(hetero) arylmethyloxy-4 phenyl tetrazole et oxadiazole, leur procede de preparation et leur application en therapeutique.

Publications (1)

Publication Number Publication Date
ATE117997T1 true ATE117997T1 (de) 1995-02-15

Family

ID=9387765

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91900836T ATE117997T1 (de) 1989-11-24 1990-11-23 4-(hetero)arylmethyloxy-phenyl-diazolderivate, verfahren zu deren herstellung und ihre therapeutische verwendung.

Country Status (7)

Country Link
EP (1) EP0502110B1 (de)
JP (1) JPH05508620A (de)
AT (1) ATE117997T1 (de)
CA (1) CA2073064A1 (de)
DE (1) DE69016672T2 (de)
FR (1) FR2655044B1 (de)
WO (1) WO1991008201A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5744500A (en) 1990-01-03 1998-04-28 Teva Pharmaceutical Industries, Ltd. Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
FR2712886B1 (fr) * 1993-11-26 1996-01-05 Synthelabo Dérivés de 1,3,4-oxadiazol-2(3H)-one, leur préparation et leur application en thérapeutique.
FR2715155B1 (fr) * 1994-01-19 1996-07-26 Mayoly Spindler Inhibiteurs de la monoamine oxydase B et leurs procédés de préparation.
FR2766485B1 (fr) * 1997-07-23 2002-05-24 Synthelabo Derives de 2,4-dihydro-3h-1,2,4-triazol-3-one, leur prparation et leur application en therapeutique

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR8005M (de) * 1967-05-24 1970-07-27
US3597429A (en) * 1968-02-15 1971-08-03 Miles Lab Derivatives of tetrazolyl alkanoic acids
US3865570A (en) * 1972-02-28 1975-02-11 Ici Ltd Plant growth stunting process
JPH021482A (ja) * 1988-02-25 1990-01-05 Toshiba Corp ヘテロ環化合物およびこれを含有する液晶材料を用いた液晶素子
FR2631827B1 (fr) * 1988-05-27 1992-03-27 Delalande Sa Nouveaux derives d'(hetero)aryl-5 tetrazole, leur procede de preparation et leur application en therapeutique

Also Published As

Publication number Publication date
WO1991008201A1 (fr) 1991-06-13
EP0502110A1 (de) 1992-09-09
DE69016672T2 (de) 1995-09-07
DE69016672D1 (de) 1995-03-16
FR2655044A1 (fr) 1991-05-31
EP0502110B1 (de) 1995-02-01
JPH05508620A (ja) 1993-12-02
FR2655044B1 (fr) 1995-03-03
CA2073064A1 (en) 1991-05-25

Similar Documents

Publication Publication Date Title
CY1108792T1 (el) Παραγωγα διοξανιου-2-αλκυλκαρβαμικου, η παρασκευη τους και η εφαρμογη τους στην θεραπευτικη αγωγη
ATE240314T1 (de) Kristalle von benzimidazolderivate und verfahren zu ihrer herstellung
HUP9802323A2 (hu) Pirimidinszármazékok, eljárás előállításukra és az ezeket tartalmazó gyógyászati készítmények
DE69923300D1 (de) Cycloalken-derivate, verfahren zu ihrer herstellung und ihre verwendung
EP0242789A3 (de) Chinolinderivate und Verfahren zu ihrer Herstellung
ATE206401T1 (de) Zwischenprodukte für die herstellung von derivaten der 4-oxochinolin-3-carbonsäure
CA2324418A1 (en) Novel opiate compounds, methods of making and methods of use
IE41539L (en) Chroman derivatives.
KR960701018A (ko) 제초성의 헤테로사이클릭-치환된 피리딘(Herbicidal heterocyclic-substituted pyridines)
ATE57699T1 (de) Pyridoncarbonsauere-derivate und verfahren zu ihrer herstellung.
KR910007883A (ko) 퀴놀린 유도체, 그의 제조방법 및 용도
IE862630L (en) 3-VINYL AND 3-ETHYNYL-ß-CARBOLINES
CA2085201A1 (en) New pyridyl derivatives, pharmaceutical compositions containing these compounds and processes for preparing them
SE7509271L (sv) Sett att framstella kinoxalin- och kinazolinderivat
DE59808284D1 (de) Cycloalkylalkancarbonsäureamide, deren herstellung und verwendung
ATE37183T1 (de) Chinazolin- und isochinolin-derivate.
ES2039221T3 (es) Procedimiento para producir derivados de piridazinona.
DE69016672T2 (de) 4-(hetero)arylmethyloxy-phenyl-diazolderivate, verfahren zu deren herstellung und ihre therapeutische verwendung.
YU41886B (en) Process for obtaining a new pyrrolyl- pyridazine amine derivatives
EP0350176A3 (de) Verfahren zur Herstellung von Pyrazolkarbonsäure und Derivaten
DE3867899D1 (de) Verfahren zur herstellung von 4-amino-androstendion-derivaten.
KR910000133A (ko) 아민
KR890016018A (ko) 6-옥소-피리다진 유도체류, 이들 화합물의 제조방법과 그 함유 의약품
HUP9900642A2 (hu) Símaizom sejtburjánzást gátló 2-szubsztituált benzimidazolszármazékok, eljárás előállításukra és alkalmazásuk gyógyszerkészítmények előállítására
ES2089097T3 (es) Procedimiento para la fabricacion de derivados de bencilftalacinona y sales de la misma.